[이슈+]Pfizer followed by Modena … United States seems to start vaccination next week

The COVID-19 vaccine from the US biopharmaceutical company Modena is expected to get approval from the US authorities on the 18th. It means that vaccination can start next week as soon as possible. It will be the second COVID-19 vaccine available in the United States after the Pfizer vaccine.

According to CNN on the 15th (local time), the US Food and Drug Administration (FDA) evaluated the preventive effect of modders or vaccines in a report published that day as “meets the necessary criteria for approval of emergency use “.

If the advisory committee’s recommendation for use is followed, the Modena vaccine is expected to be approved for emergency use on day 18.

The Pfizer vaccine was approved on day 11 and vaccination started on day 14. Modena’s vaccine will be approved one week later than the Pfizer vaccine.

US authorities plan to begin vaccinating immediately after approval. If the plan succeeds, the US will take back the world’s first vaccination record for the Pfizer vaccine, which was stolen by the UK, with a modder vaccine.

The Modena vaccine is supposed to be given twice every four weeks. After vaccination, 94.1% of the COVID-19 prevention effect was confirmed.

Regarding stability, it was evaluated that “the security problem that may interfere with the approval of emergency use cannot be identified”. However, side effects such as injection site hypersensitivity reaction, boredom and headache have been confirmed.

Like the Pfizer vaccine, the Modena vaccine is a vaccine that uses “messenger ribonucleic acid” (mRNA), the so-called “messenger RNA”, which contains the genetic information of the virus.

While mRNA is used to increase effectiveness, the development period of the vaccine could be significantly shortened, but it is a burden that it is the first time it is marketed. Also, mRNA is weak to heat and chemicals. The Pfizer vaccine requires an environment of minus 70 degrees Celsius for transport and storage. However, the modern or the vaccine can be stored in a 2-8 degree environment, so the inoculation site is less restricted.

Modena said it could launch the vaccine in the United States one day after FDA approval and would deliver 6 million doses to more than 3,200 locations.